Literature DB >> 1472554

Human responses to colonoscopy.

D Parker.   

Abstract

Registered nurses must not only anticipate the usual responses that a patient may experience during colonoscopy but also must be able to predict and prevent atypical responses. Normal healthy compensation (physiologic) and decompensation (pathophysiologic) responses as well as observable and measurable patient behaviors are included in a comprehensive assessment. In developing a plan of care, nurses must also consider the patient's past experiences, knowledge, and usual coping mechanisms. Professional nurses are responsible and accountable for diagnosing and treating human responses to actual or potential health problems. A human response framework emphasizes the multiple perspectives in which humans adapt to health and illness. This framework provides a model to clarify what constitutes a human response.

Entities:  

Mesh:

Year:  1992        PMID: 1472554     DOI: 10.1097/00001610-199212000-00005

Source DB:  PubMed          Journal:  Gastroenterol Nurs        ISSN: 1042-895X            Impact factor:   0.978


  3 in total

1.  Comparison of double pants with single pants on satisfaction with colonoscopy.

Authors:  Sook Hee Chung; Soo Jung Park; Jong Suk Hong; Jee Young Hwang; Sin Ae Lee; Kyung Ran Kim; Hye Sun Lee; Sung Pil Hong; Jae Hee Cheon; Tae Il Kim; Won Ho Kim
Journal:  World J Gastroenterol       Date:  2013-07-14       Impact factor: 5.742

2.  Panic Attack during Elective Gastrointestinal Endoscopy.

Authors:  Charalampos Mitsonis; Nikolaos Dimopoulos; Marianna Zavrou; Vassiliki Psarra; Christos Giofkos; Christos Fiorakis; Athanasios Dimitriadis; Dimitrios Valavanis; Eleni Vousoura; Iannis Zervas; Efstathios Papavassiliou
Journal:  Gastroenterol Res Pract       Date:  2011-10-04       Impact factor: 2.260

3.  Impact of anxiety on sedative medication dosage in patients undergoing esophagogastroduodenoscopy.

Authors:  Bünyamin Gürbulak; Muhammed Zübeyr Üçüncü; Erkan Yardımcı; Ebru Kırlı; Filiz Tüzüner
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2018-02-15       Impact factor: 1.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.